Shanghai, China

Jianyan Xu

USPTO Granted Patents = 3 

Average Co-Inventor Count = 6.3

ph-index = 1


Company Filing History:


Years Active: 2019-2025

Loading Chart...
3 patents (USPTO):

Title: Innovations and Contributions of Inventor Jianyan Xu

Introduction

Jianyan Xu is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of medicine, particularly in the development of innovative cancer treatments. With a total of three patents to his name, Xu's work has the potential to impact the lives of many patients.

Latest Patents

Jianyan Xu's latest patents include the "Anti-B7H3 antibody-exatecan analog conjugate and medicinal use thereof." This invention discloses an anti-B7H3 antibody-exatecan analog conjugate, along with a preparation method and its anti-tumor medicinal use. Another notable patent is the "Anti-c-Met antibody and anti-c-Met antibody-cytotoxic drug conjugate and pharmaceutical use thereof." This patent provides an anti-c-Met antibody or an antigen binding fragment, as well as a conjugate that combines the antibody with a cytotoxic drug, aimed at treating cancer.

Career Highlights

Throughout his career, Jianyan Xu has worked with reputable companies such as Jiangsu Hengrui Medicine Company Ltd. and Shanghai Hengrui Pharmaceutical Co., Ltd. His experience in these organizations has allowed him to develop and refine his innovative ideas in the pharmaceutical industry.

Collaborations

Jianyan Xu has collaborated with notable colleagues, including Weikang Tao and Ying Zhang, who is a woman. These collaborations have likely contributed to the success of his inventions and the advancement of cancer treatment methodologies.

Conclusion

Jianyan Xu's contributions to the field of medicine through his innovative patents demonstrate his commitment to improving cancer treatment. His work continues to inspire future advancements in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…